Sign In
Buy MRK
$115.49
+0.320 (+0.278%)
At Close: Jun 17, 2026
Where Will Merck Stock Be In 4 Years?
09:45am, Friday, 24'th Feb 2023
Merck & Co., Inc. stock has performed very well for me during the past two years. It often takes several years for the prices of overvalued or undervalued stocks to reflect today's earnings-based valu
Merck & Co. Inc. MRK, +1.31% and privately held Ridgeback Biotherapeutics said Friday a panel advising the European regulator has recommended refusing the marketing authorization for their jointly dev
Don't Get Panicked Into Selling Off Merck Shares
06:45am, Friday, 24'th Feb 2023
The current drop in 2023 sales likely won't matter in the long term.
Moderna (MRNA) Lags on Q4 Earnings, COVID Jab Sales Down Y/Y
05:08pm, Thursday, 23'rd Feb 2023 Zacks Investment Research
Moderna's (MRNA) fourth-quarter earnings and sales miss expectations. Management reiterates guidance to record a minimum of $5 billion from COVID vaccine sales in 2023.
The 12 Best Stocks to Buy Now
04:28pm, Thursday, 23'rd Feb 2023
The lesson of the past two years: Be ready for anything. Our best stocks to buy now reflect opportunities amid an uncertain economic backdrop.
Moderna and Merck receive FDA breakthrough status for personalized cancer vaccine
07:33am, Thursday, 23'rd Feb 2023
CNBC's Meg Tirrell reports on news from Moderna and Merck.
Merck: KEYTRUDA And GARDASIL Sales Are Expected To Rise
06:20am, Thursday, 23'rd Feb 2023 Seeking Alpha
In 2022, Merck’s KEYTRUDA and GARDASIL worldwide sales increased by 27% YoY. Read more to see my thoughts on MRK and why the stock is a Buy.
Merck: KEYTRUDA And GARDASIL Sales Are Expected To Rise
01:20am, Thursday, 23'rd Feb 2023
In 2022, Merck's KEYTRUDA and GARDASIL worldwide sales increased by 27% YoY. The immunotherapy and HPV vaccines markets are expected to grow in the following years.
Moderna, Merck receives FDA breakthrough status for personalized cancer vaccine
04:46pm, Wednesday, 22'nd Feb 2023
CNBC's Meg Tirrell joins 'Closing Bell: Overtime' to report on Merck and Moderna receiving FDA breakthrough status for a personalized cancer vaccine.
Intel’s dividend cut shows the need for quality. Here are 20 dividend stocks screened by UBS.
04:41pm, Wednesday, 22'nd Feb 2023 MarketWatch
Intel cut its dividend by 66% after analysts' estimates showed the chip maker was expected to run negative cash flow for the next two full years.
Benzinga's Top Ratings Upgrades, Downgrades For February 22, 2023
03:00pm, Wednesday, 22'nd Feb 2023 Benzinga
Upgrades
Maxim Group upgraded the previous rating for TOP Ships Inc (NASDAQ:TOPS) from Hold to Buy. NoneThe stock has a 52-week-high of $32.80 and a 52-week-low of $0.75. At the end of the last tradin
Expert Ratings for Merck & Co
02:01pm, Wednesday, 22'nd Feb 2023 Benzinga
Merck & Co (NYSE:MRK) has observed the following analyst ratings within the last quarter:
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
2
7
1
0
0
Last 30D
0
1
This Recession-Proof Company Has a Best-in-Class Dividend
12:30pm, Wednesday, 22'nd Feb 2023 The Motley Fool
Pfizer's highly attractive valuation, rock-solid dividend program, and enormous yield put it at the top of its big pharma peer group.
Merck & Co.: Running A Bit Hot
10:51am, Wednesday, 22'nd Feb 2023
Merck has seen a significant valuation re-rating take place over the past years. This comes amidst the success of Keytruda, which creates some dependency risks as well.
Jim Cramer Lists 6 Conditions For Market Selloff To End Amid 'Discouraging' Inflation Data
04:32am, Wednesday, 22'nd Feb 2023 Benzinga
Prominent market commentator Jim Cramer on Tuesday suggested a six-point checklist of events that must happen before declaring an end to the market sell-off.
Major Wall Street indices closed over 2%
